Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / COM SHS
-
Total 13F shares
-
109,919
-
Share change
-
+109,917
-
Total reported value
-
$1,479,506
-
Price per share
-
$13.46
-
Number of holders
-
13
-
Value change
-
+$1,479,479
-
Number of buys
-
12
Institutional Holders of Serina Therapeutics, Inc. - COM SHS (SER) as of Q1 2024
As of 31 Mar 2024,
Serina Therapeutics, Inc. - COM SHS (SER) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
109,919 shares.
The largest 10 holders included
BROADWOOD CAPITAL INC, VANGUARD GROUP INC, BlackRock Inc., CITIGROUP INC, Tower Research Capital LLC (TRC), WELLS FARGO & COMPANY/MN, Riggs Asset Managment Co. Inc., MORGAN STANLEY, ALBION FINANCIAL GROUP /UT, and OSAIC HOLDINGS, INC..
This page lists
13
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.